Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab autoinjector versus placebo in chronic plaque psoriasis
2012-002609-22Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of secukinumab in plaque psoriasis, sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2012-002609-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002609-22.